Clinical Trials Browser

INDUSTRY × Lymphoma, T-Cell × Rituximab × Clear all

Bronchiolitis Obliterans Syndrome, Leukemia, Lymphoma, Follicular, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, B-Cell, Lymphoma, T-Cell, Lymphoma, T-Cell, Cutaneous

NCT01421667 2016-11-28

A Study of Brentuximab Vedotin in Relapsed or Refractory Non-Hodgkin Lymphoma

Phase 2 Completed

176 enrolled 30 charts

Lymphoid

Hematologic Diseases, Lymphoma, Lymphoma, Non-Hodgkin, Lymphoma, B-Cell, Lymphoma, T-Cell, Lymphoma, Large B-Cell, Diffuse

Clinical Trials

Phase 1/2a Dose Escalation Study in Participants With CLL, SLL, or NHL

A Study of Brentuximab Vedotin in Relapsed or Refractory Non-Hodgkin Lymphoma